IN2015DN01119A - - Google Patents

Info

Publication number
IN2015DN01119A
IN2015DN01119A IN1119DEN2015A IN2015DN01119A IN 2015DN01119 A IN2015DN01119 A IN 2015DN01119A IN 1119DEN2015 A IN1119DEN2015 A IN 1119DEN2015A IN 2015DN01119 A IN2015DN01119 A IN 2015DN01119A
Authority
IN
India
Prior art keywords
compounds
disclosed
methods
intermediates
synthesis
Prior art date
Application number
Inventor
Ende Christopher William Am
Michael Eric Green
Douglas Scott Johnson
Gregory Wayne Kauffman
Christopher John Odonnell
Nandini Chaturbhai Patel
Martin Youngjin Pettersson
Antonia Friederike Stepan
Cory Michael Stiff
Chakrapani Subramanyam
Tuan Phong Tran
Patrick Robert Verhoest
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IN2015DN01119A publication Critical patent/IN2015DN01119A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

Compounds and pharmaceutically acceptable salts of the compounds are disclosed wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions methods of treatment methods of synthesis and intermediates are also disclosed.
IN1119DEN2015 2012-09-21 2013-09-06 IN2015DN01119A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261703969P 2012-09-21 2012-09-21
PCT/IB2013/058347 WO2014045156A1 (en) 2012-09-21 2013-09-06 Novel bicyclic pyridinones

Publications (1)

Publication Number Publication Date
IN2015DN01119A true IN2015DN01119A (en) 2015-06-26

Family

ID=49585452

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1119DEN2015 IN2015DN01119A (en) 2012-09-21 2013-09-06

Country Status (47)

Country Link
US (3) US8916564B2 (en)
EP (1) EP2897956B1 (en)
JP (1) JP5844018B2 (en)
KR (1) KR101725696B1 (en)
CN (1) CN104662021B (en)
AP (1) AP2015008277A0 (en)
AR (1) AR092628A1 (en)
AU (1) AU2013319845B2 (en)
BR (1) BR112015006436A2 (en)
CA (1) CA2882386C (en)
CL (1) CL2015000717A1 (en)
CR (1) CR20150053A (en)
CU (1) CU20150021A7 (en)
CY (1) CY1118662T1 (en)
DK (1) DK2897956T3 (en)
DO (1) DOP2015000069A (en)
EA (1) EA026668B1 (en)
EC (1) ECSP15015594A (en)
ES (1) ES2609987T3 (en)
GE (1) GEP201706659B (en)
GT (1) GT201500069A (en)
HK (1) HK1206013A1 (en)
HR (1) HRP20161558T1 (en)
HU (1) HUE031248T2 (en)
IL (1) IL237163A (en)
IN (1) IN2015DN01119A (en)
LT (1) LT2897956T (en)
MA (1) MA37886B1 (en)
MD (1) MD4583B1 (en)
ME (1) ME02571B (en)
MX (1) MX360599B (en)
MY (1) MY181891A (en)
NI (1) NI201500038A (en)
NZ (1) NZ704863A (en)
PE (1) PE20150686A1 (en)
PH (1) PH12015500376B1 (en)
PL (1) PL2897956T3 (en)
PT (1) PT2897956T (en)
RS (1) RS55426B1 (en)
SG (1) SG11201501074WA (en)
SI (1) SI2897956T1 (en)
TN (1) TN2015000084A1 (en)
TW (1) TWI500616B (en)
UA (1) UA110688C2 (en)
UY (1) UY35039A (en)
WO (1) WO2014045156A1 (en)
ZA (1) ZA201501195B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA110688C2 (en) 2012-09-21 2016-01-25 Пфайзер Інк. Bicyclic pirydynony
EP2953949B1 (en) 2012-12-20 2016-09-28 Janssen Pharmaceutica NV Novel tricyclic 3,4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione derivatives as gamma secretase modulators
KR102171710B1 (en) 2013-01-17 2020-10-30 얀센 파마슈티카 엔.브이. Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
WO2015049616A1 (en) * 2013-10-04 2015-04-09 Pfizer Inc. Novel bicyclic pyridinones as gamma-secretase modulators
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators
BR112016022519A8 (en) * 2014-04-01 2018-03-06 Pfizer chromene and 1,1a, 2,7b-tetrahydrocyclopropa [c] chromene pyridopyrazinedione as gamma secretase modulators
KR102000382B1 (en) * 2015-02-03 2019-07-15 화이자 인코포레이티드 The novel cyclopropabenzofuranylpyridopyrazazine
US9802927B2 (en) 2015-06-10 2017-10-31 Denali Therapeutics, Inc. Oxadiazine compounds and methods of use thereof
CN109311876B (en) 2016-06-16 2022-05-03 豪夫迈·罗氏有限公司 Heteroaryl estrogen receptor modulators and uses thereof
US10925872B2 (en) 2016-12-16 2021-02-23 Pipeline Therapeutics, Inc. Methods of treating cochlear synaptopathy
BR112021006092A2 (en) 2018-10-02 2021-07-20 Frequency Therapeutics, Inc. pharmaceutical compositions comprising optical therapeutic agents and related methods
MX2021012258A (en) 2019-04-08 2022-01-04 Frequency Therapeutics Inc Combination of chir99021 and valproic acid for treating hearing loss.
CR20220316A (en) 2019-12-06 2022-10-07 Vertex Pharma Substituted tetrahydrofurans as modulators of sodium channels
CN113402490B (en) * 2021-03-29 2023-01-03 白银京宇新药业有限公司 Preparation method of 1,2,6, 7-tetrahydro-8H-indeno [5,4-b ] furan-8-one
US11827627B2 (en) 2021-06-04 2023-11-28 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
CN114034792A (en) * 2021-11-09 2022-02-11 山东新华制药股份有限公司 Liquid chromatography analysis method for detecting content of chlorone

Family Cites Families (134)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419788A (en) 1972-08-02 1975-12-31 Pfizer Herbicidal method using 2-trifuluromethyl-4-quinolinols
WO1992000075A1 (en) 1990-06-29 1992-01-09 Pfizer Inc. Pyridopyrazine derivatives for treating substance abuse and addiction
ATE161530T1 (en) 1992-09-04 1998-01-15 Takeda Chemical Industries Ltd CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE
EP0683234B2 (en) 1993-01-25 2007-06-06 Takeda Chemical Industries, Ltd. Antibody against beta-amyloid or their derivative and use thereof
TW394773B (en) 1995-03-24 2000-06-21 Takeda Chemical Industries Ltd Cyclic compounds for antagonizing tachykinin receptor, substance p receptor and neurokinin a receptor, their production and pharmaceutical composition
DE19709877A1 (en) 1997-03-11 1998-09-17 Bayer Ag 1,5-dihydro-pyrazolo [3,4-d] pyrimidinone derivatives
US8173127B2 (en) 1997-04-09 2012-05-08 Intellect Neurosciences, Inc. Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
WO1998044955A1 (en) 1997-04-09 1998-10-15 Mindset Ltd. Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
GB9722520D0 (en) 1997-10-24 1997-12-24 Pfizer Ltd Compounds
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US6743427B1 (en) 1997-12-02 2004-06-01 Neuralab Limited Prevention and treatment of amyloidogenic disease
RU2209788C2 (en) 1998-03-03 2003-08-10 Ппг Индастриз Огайо, Инк. Impregnated fiberglass strands and products containing thereof
US20020132817A1 (en) 1998-03-19 2002-09-19 Hideaki Natsugari Heterocyclic compounds, their production and use
EP1145714A4 (en) 1998-11-27 2004-12-15 Takeda Chemical Industries Ltd Drugs
CZ306683B6 (en) 2000-02-24 2017-05-03 Washington University A medication for the prevention or treatment of preclinical or clinical Alzheimer's disease
DE10045112A1 (en) 2000-09-11 2002-03-21 Merck Patent Gmbh Use of indole derivatives for the treatment of diseases of the central nervous system
EP1335738A4 (en) 2000-11-03 2004-09-08 Proteotech Inc Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
US20040192898A1 (en) 2001-08-17 2004-09-30 Jia Audrey Yunhua Anti-abeta antibodies
US20030195205A1 (en) 2001-11-02 2003-10-16 Pfizer Inc. PDE9 inhibitors for treating cardiovascular disorders
DE10238724A1 (en) 2002-08-23 2004-03-04 Bayer Ag New 6-alkyl-1,5-dihydro-4H-pyrazolo-(3,4-d)-pyrimidin-4-ones useful as selective phosphodiesterase 9A inhibitors for improving attention, concentration, learning and/or memory performance
DE10238723A1 (en) 2002-08-23 2004-03-11 Bayer Ag Phenyl substituted pyrazolyprimidines
EP1549315A4 (en) 2002-09-11 2007-05-23 Merck & Co Inc Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
US20040146512A1 (en) 2002-10-09 2004-07-29 Arnon Rosenthal Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
EP1551809A1 (en) 2002-10-09 2005-07-13 Pfizer Products Inc. Pyrazole compounds for treatment of neurodegenerative disorders
AU2003301439A1 (en) 2002-10-16 2004-05-04 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
US20040220186A1 (en) 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
EP1638935A1 (en) 2003-06-19 2006-03-29 Pfizer Products Inc. Nk1 antagonist
BRPI0413709A (en) 2003-08-21 2006-10-17 Pfizer Prod Inc compounds for the treatment of neurodegenerative disorders
CA2538220A1 (en) 2003-09-09 2005-03-24 Takeda Pharmaceutical Company Limited Use of antibody
GB0327319D0 (en) 2003-11-24 2003-12-24 Pfizer Ltd Novel pharmaceuticals
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
JP2007519734A (en) 2004-01-28 2007-07-19 メルク　エンド　カムパニー　インコーポレーテッド Aminocyclopentylpyridopyrazinone chemokine receptor activity modulator
BRPI0507374A (en) 2004-02-02 2007-07-10 Pfizer Prod Inc histamine-3 receptor modulators
AU2005227258A1 (en) 2004-03-09 2005-10-06 Merck & Co., Inc. HIV integrase inhibitors
AU2005225635B2 (en) 2004-03-23 2010-06-24 Pfizer Products Inc. Imidazole compounds for the treatment of neurodegenerative disorders
JP2007532665A (en) 2004-04-14 2007-11-15 ギリアード サイエンシーズ， インコーポレイテッド Phosphonate analogues of HIV integrase inhibitor compounds
US7456164B2 (en) 2004-05-07 2008-11-25 Pfizer, Inc 3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
EP1595881A1 (en) 2004-05-12 2005-11-16 Pfizer Limited Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
US7807165B2 (en) 2004-07-30 2010-10-05 Rinat Neuroscience Corp. Antibodies directed against amyloid-beta peptide and methods using same
GB0423356D0 (en) 2004-10-21 2004-11-24 Merck Sharp & Dohme Therapeutic agents
FR2877015B1 (en) 2004-10-21 2007-10-26 Commissariat Energie Atomique NANOSTRUCTURE COATING AND COATING PROCESS.
US20090074775A1 (en) 2004-12-22 2009-03-19 David Michael Holtzman Use Of Anti-AB Antibody To Treat Traumatic Brain Injury
MY148086A (en) 2005-04-29 2013-02-28 Rinat Neuroscience Corp Antibodies directed against amyloid-beta peptide and methods using same
WO2006121831A2 (en) 2005-05-10 2006-11-16 Merck & Co., Inc. Hiv integrase inhibitors
ATE493413T1 (en) 2005-05-12 2011-01-15 Pfizer ANHYDROUS CRYSTALLINE FORMS OF N-Ä1,2- ETHOXYETHYL)-5-(N-ETHYL-N-METHYLAMINOÜ-7-(4- METHYLPYRIDINE-2-YL-AMINOÜ-1H-PYRAZOLOÄ4,3-
WO2006126083A1 (en) 2005-05-24 2006-11-30 Pharmacia & Upjohn Company Llc Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
WO2006126081A2 (en) 2005-05-24 2006-11-30 Pharmacia & Upjohn Company Llc Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
WO2006126082A2 (en) 2005-05-24 2006-11-30 Pharmacia & Upjohn Company Llc Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
JP2008543923A (en) 2005-06-22 2008-12-04 ファイザー・プロダクツ・インク Histamine-3 receptor antagonist
US20070060534A1 (en) 2005-06-30 2007-03-15 Threshold Pharmaceuticals, Inc. Anthracycline analogs
US8158673B2 (en) 2005-10-27 2012-04-17 Pfizer Inc. Histamine-3 receptor antagonists
WO2007052124A1 (en) 2005-11-04 2007-05-10 Pfizer Limited Tetrahydronaphthyridine derivative
WO2007062332A2 (en) 2005-11-18 2007-05-31 Glaxo Group Limited Novel intermediates and their use
JP2009515997A (en) 2005-11-18 2009-04-16 タケダ サン ディエゴ インコーポレイテッド Glucokinase activator
US20070117839A1 (en) 2005-11-24 2007-05-24 Eisai R&D Management Co., Ltd. Two cyclic cinnamide compound
KR20080069221A (en) 2005-11-24 2008-07-25 에자이 알앤드디 매니지먼트 가부시키가이샤 Morpholine type cinnamide compound
WO2007063385A2 (en) 2005-12-01 2007-06-07 Pfizer Products Inc. Spirocyclic amine histamine-3 receptor antagonists
WO2007069053A1 (en) 2005-12-14 2007-06-21 Pfizer Products Inc. Benzimidazole antagonists of the h-3 receptor
KR20080095885A (en) 2006-01-20 2008-10-29 쉐링 코포레이션 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
WO2007088462A1 (en) 2006-02-01 2007-08-09 Pfizer Products Inc. Spirochromane antagonists of the h-3 receptor
WO2007088450A2 (en) 2006-02-01 2007-08-09 Pfizer Products Inc. Chromane antagonist of the h-3 receptor
WO2007099423A1 (en) 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
US20090163482A1 (en) 2006-03-13 2009-06-25 Mchardy Stanton Furst Tetralines antagonists of the h-3 receptor
MX2008012456A (en) 2006-04-21 2008-10-10 Pfizer Prod Inc Pyridine[3,4-b]pyrazinones.
US7442808B2 (en) 2006-05-15 2008-10-28 Merck & Co., Inc. Antidiabetic bicyclic compounds
US8008287B2 (en) 2006-05-16 2011-08-30 Gilead Sciences, Inc. Integrase inhibitors
KR20090018963A (en) 2006-05-19 2009-02-24 에자이 알앤드디 매니지먼트 가부시키가이샤 Urea type cinnamide derivative
WO2007138431A2 (en) 2006-05-30 2007-12-06 Pfizer Products Inc. Azabicyclic ether histamine-3 antagonists
JP4585610B2 (en) 2007-01-22 2010-11-24 ファイザー・プロダクツ・インク Tosylate salt of therapeutic compound and pharmaceutical composition thereof
JP2010518083A (en) 2007-02-12 2010-05-27 メルク・シャープ・エンド・ドーム・コーポレイション Piperidine derivatives
JP2010518064A (en) 2007-02-12 2010-05-27 メルク・シャープ・エンド・ドーム・コーポレイション Piperazine derivatives for the treatment of AD and related conditions
TW200848054A (en) 2007-02-28 2008-12-16 Eisai R&D Man Co Ltd Two cyclic oxomorpholine derivatives
WO2008137102A2 (en) 2007-05-04 2008-11-13 Torreypines Therapeutics, Inc. Methods of modulating amyloid beta and compounds useful therefor
WO2008137139A1 (en) 2007-05-07 2008-11-13 Schering Corporation Gamma secretase modulators
RU2009140182A (en) 2007-05-11 2011-06-20 Ф. Хоффманн-Ля Рош Аг (Ch) HETARILANILINES AS MODULATORS FOR BETA AMYLOID
TW200908968A (en) 2007-05-29 2009-03-01 Sgx Pharmaceuticals Inc Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
WO2008153792A2 (en) 2007-06-01 2008-12-18 Schering Corporation Gamma secretase modulators
JP5495331B2 (en) 2007-06-01 2014-05-21 メルク・シャープ・アンド・ドーム・コーポレーション γ-secretase modifier
WO2008156580A1 (en) 2007-06-13 2008-12-24 Merck & Co., Inc. Triazole derivatives for treating alzheimer's disease and related conditions
WO2009005729A1 (en) 2007-06-29 2009-01-08 Schering Corporation Gamma secretase modulators
CA2695543A1 (en) 2007-08-06 2009-02-12 Schering Corporation Gamma secretase modulators
US7935815B2 (en) 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
AR068121A1 (en) 2007-08-31 2009-11-04 Eisai R&D Man Co Ltd MULTICICLICAL COMPOUNDS TO TREAT NEURODEGENERATIVE DISEASES
CA2698341A1 (en) 2007-09-06 2009-03-12 Schering Corporation Gamma secretase modulators
EP2205567A1 (en) 2007-09-28 2010-07-14 Schering Corporation Gamma secretase modulators
GB0720444D0 (en) 2007-10-18 2007-11-28 Glaxo Group Ltd Novel compounds
CN101910178A (en) 2007-11-05 2010-12-08 先灵公司 Gamma secretase modulators
EP2229375A1 (en) * 2007-12-06 2010-09-22 Schering Corporation Gamma secretase modulators
MX2010006378A (en) 2007-12-11 2010-09-07 Schering Corp Gamma secretase modulators.
EP2268636A1 (en) 2007-12-11 2011-01-05 Schering Corporation Gamma secretase modulators
CA2707492A1 (en) 2007-12-13 2009-06-18 Amgen Inc. Gamma secretase modulators
KR101244517B1 (en) 2008-01-11 2013-03-18 에프. 호프만-라 로슈 아게 Modulators for amyloid beta
JP5328816B2 (en) 2008-02-22 2013-10-30 エフ．ホフマン−ラ ロシュ アーゲー Modulator of amyloid β
US20110027264A1 (en) 2008-02-29 2011-02-03 Xianhai Huang Gamma secretase modulators for the treatment of alzheimer's disease
US20100137320A1 (en) 2008-02-29 2010-06-03 Schering Corporation Gamma secretase modulators
JP2011520809A (en) 2008-05-05 2011-07-21 アムジエン・インコーポレーテツド Urea compounds as gamma secretase modulators
FR2933700B1 (en) * 2008-07-08 2010-07-30 Sanofi Aventis PYRIDINO-PYRIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
TW201006801A (en) 2008-07-18 2010-02-16 Lilly Co Eli Imidazole carboxamides
US8685972B2 (en) 2008-08-13 2014-04-01 Merck Sharp & Dohme Corp. Pyrimidine derivatives for treatment of alzheimer's disease
US20110251172A1 (en) 2008-08-13 2011-10-13 Rivkin Alexey A Purine derivatives for treatment of alzheimer's disease
MX2011002002A (en) 2008-08-27 2011-03-29 Eisai R&D Man Co Ltd Process for preparing certain cinnamide compounds.
WO2010040661A1 (en) 2008-10-09 2010-04-15 F. Hoffmann-La Roche Ag Modulators for amyloid beta
JP2012507512A (en) 2008-11-06 2012-03-29 アストラゼネカ・アクチエボラーグ Amyloid β modulator
CA2742602A1 (en) 2008-11-06 2010-05-14 Schering Corporation Gamma secretase modulators
US20110263529A1 (en) 2008-11-06 2011-10-27 Ruo Xu Gamma secretase modulators
JP5378532B2 (en) 2008-11-10 2013-12-25 エフ．ホフマン−ラ ロシュ アーゲー Heterocyclic γ-secretase modulator
US20110313001A1 (en) 2008-12-16 2011-12-22 Christian Fischer Triazole derivatives for treatment of alzheimer's disease
WO2010071741A1 (en) 2008-12-16 2010-06-24 Merck Sharp & Dohme Corp. Triazole derivatives for treatment of alzheimer's disease
PA8854101A1 (en) 2008-12-18 2010-07-27 Ortho Mcneil Janssen Pharm IMIDAZOL BICYCLIC DERIVATIVES REPLACED AS MODULATORS OF GAMMA SECRETASA
DK2379525T3 (en) 2008-12-19 2015-10-19 Boehringer Ingelheim Int Cyclic pyrimidin-4-carboxamides, as CCR2 receptor antagonists for the treatment of inflammation, asthma and COPD
TW201035103A (en) 2008-12-22 2010-10-01 Schering Corp Gamma secretase modulators
CA2747744A1 (en) 2008-12-22 2010-07-01 Theodros Asberom Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
ES2481715T3 (en) 2009-02-06 2014-07-31 Janssen Pharmaceuticals, Inc. Novel substituted bicyclic heterocyclic compounds as gamma-secretase modulators
TWI461425B (en) * 2009-02-19 2014-11-21 Janssen Pharmaceuticals Inc Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
JP2012051805A (en) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd Method for producing tetrahydrotriazolopyridine derivative
AU2010218667A1 (en) 2009-02-26 2011-07-21 Eisai R&D Management Co., Ltd. Salt of tetrahydrotriazolopyridine derivative and crystal thereof
JP2012121809A (en) 2009-02-26 2012-06-28 Eisai R & D Management Co Ltd Method for producing polycyclic compound and intermediate thereof
JP2012051807A (en) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd Arylimidazole compound
JP2012051806A (en) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd Imidazolylpyrazine derivative
CA2751534A1 (en) 2009-03-03 2010-09-10 Pfizer Inc. Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
IN2012DN00548A (en) 2009-08-07 2015-06-12 Dow Agrosciences Llc
JP2013508350A (en) * 2009-10-20 2013-03-07 ファイザー・インク Novel heteroarylimidazoles and heteroaryltriazoles as gamma-secretase modulators
RU2573569C2 (en) * 2009-12-22 2016-01-20 Вертекс Фармасьютикалз Инкорпорейтед Isoindolinone-based phosphatidylinositol-3-kinase inhibitors
EP2691393B1 (en) 2011-03-31 2016-09-14 Pfizer Inc Novel bicyclic pyridinones
US9181245B2 (en) * 2012-05-16 2015-11-10 Janssen Pharmaceuticals, Inc. Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's disease
UA110688C2 (en) 2012-09-21 2016-01-25 Пфайзер Інк. Bicyclic pirydynony
TWI614238B (en) 2012-09-21 2018-02-11 必治妥美雅史谷比公司 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
EP2953949B1 (en) 2012-12-20 2016-09-28 Janssen Pharmaceutica NV Novel tricyclic 3,4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione derivatives as gamma secretase modulators
KR102171710B1 (en) 2013-01-17 2020-10-30 얀센 파마슈티카 엔.브이. Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
WO2015049616A1 (en) 2013-10-04 2015-04-09 Pfizer Inc. Novel bicyclic pyridinones as gamma-secretase modulators
EP3119347B1 (en) 2014-03-21 2023-06-07 Align Technology, Inc. Segmented orthodontic appliance with elastics
BR112016022519A8 (en) 2014-04-01 2018-03-06 Pfizer chromene and 1,1a, 2,7b-tetrahydrocyclopropa [c] chromene pyridopyrazinedione as gamma secretase modulators

Also Published As

Publication number Publication date
AU2013319845B2 (en) 2017-09-14
TN2015000084A1 (en) 2016-06-29
DK2897956T3 (en) 2017-01-16
AP2015008277A0 (en) 2015-02-28
LT2897956T (en) 2017-01-10
HK1206013A1 (en) 2015-12-31
ECSP15015594A (en) 2017-08-31
NI201500038A (en) 2015-06-05
US20160024088A1 (en) 2016-01-28
ME02571B (en) 2017-06-20
JP2015529238A (en) 2015-10-05
CY1118662T1 (en) 2017-07-12
UY35039A (en) 2014-04-30
HRP20161558T1 (en) 2016-12-30
KR20150044948A (en) 2015-04-27
PE20150686A1 (en) 2015-05-23
MA37886A1 (en) 2016-02-29
EA026668B1 (en) 2017-05-31
DOP2015000069A (en) 2015-05-15
BR112015006436A2 (en) 2017-07-04
CA2882386A1 (en) 2014-03-27
MD4583B1 (en) 2018-07-31
MX2015003637A (en) 2015-06-05
EA201590319A1 (en) 2015-09-30
CL2015000717A1 (en) 2015-06-19
CR20150053A (en) 2015-03-25
US9751877B2 (en) 2017-09-05
CN104662021A (en) 2015-05-27
KR101725696B1 (en) 2017-04-10
AR092628A1 (en) 2015-04-29
IL237163A0 (en) 2015-04-30
CN104662021B (en) 2016-08-24
TWI500616B (en) 2015-09-21
PH12015500376A1 (en) 2015-04-20
MX360599B (en) 2018-11-08
MY181891A (en) 2021-01-12
CU20150021A7 (en) 2015-08-27
GEP201706659B (en) 2017-04-25
SG11201501074WA (en) 2015-05-28
PL2897956T3 (en) 2017-05-31
EP2897956A1 (en) 2015-07-29
UA110688C2 (en) 2016-01-25
EP2897956B1 (en) 2016-11-09
CA2882386C (en) 2017-11-28
PH12015500376B1 (en) 2015-04-20
MA37886B1 (en) 2016-09-30
US9193726B2 (en) 2015-11-24
PT2897956T (en) 2017-01-13
TW201425311A (en) 2014-07-01
IL237163A (en) 2016-12-29
HUE031248T2 (en) 2017-06-28
WO2014045156A1 (en) 2014-03-27
AU2013319845A1 (en) 2015-02-26
SI2897956T1 (en) 2017-02-28
US20150072990A1 (en) 2015-03-12
US8916564B2 (en) 2014-12-23
ZA201501195B (en) 2016-01-27
ES2609987T3 (en) 2017-04-25
GT201500069A (en) 2016-03-01
NZ704863A (en) 2017-03-31
RS55426B1 (en) 2017-04-28
MD20150023A2 (en) 2015-07-31
US20140088111A1 (en) 2014-03-27
JP5844018B2 (en) 2016-01-13

Similar Documents

Publication Publication Date Title
IN2015DN01119A (en)
IN2014MN02598A (en)
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
IN2015DN01156A (en)
PH12014501542B1 (en) Substituted pyrrolidine -2- carboxamides
IN2014DN09434A (en)
IN2014DN09352A (en)
IN2012DN03182A (en)
UA109010C2 (en) Morpholino pyrividines and their use in therapy
MX345928B (en) Therapeutically active compositions and their methods of use.
IN2014DN09348A (en)
MX2016006336A (en) Pyrazolopyrimidine compounds.
MX343706B (en) Novel heterocyclic derivatives.
IN2014CN04530A (en)
EA201390381A1 (en) TRIAZINOXADIAZOLES
WO2014045162A8 (en) ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS
EA201500298A1 (en) ALCOXYPHAZOLES AS ACTIVATORS OF SOLUBLE GUANYLATZYCLASES
MX2012013274A (en) Novel pyrimidine derivatives.
IN2015DN01151A (en)
IN2014DN09347A (en)
WO2012135615A3 (en) Enopeptins, uses thereof, and methods of synthesis thereto
GB201209587D0 (en) Therapeutic compounds
MX340574B (en) Imidazo pyrazines.
MX2013008340A (en) Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer.
IN2013DN02555A (en)